Ludwig Cancer Center, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA.
Harvard Medical School, Boston, MA 02115, USA.
Cell Metab. 2019 May 7;29(5):1166-1181.e6. doi: 10.1016/j.cmet.2019.01.020. Epub 2019 Feb 21.
Cells are subjected to oxidative stress during the initiation and progression of tumors, and this imposes selective pressure for cancer cells to adapt mechanisms to tolerate these conditions. Here, we examined the dependency of cancer cells on glutathione (GSH), the most abundant cellular antioxidant. While cancer cell lines displayed a broad range of sensitivities to inhibition of GSH synthesis, the majority were resistant to GSH depletion. To identify cellular pathways required for this resistance, we carried out genetic and pharmacologic screens. Both approaches revealed that inhibition of deubiquitinating enzymes (DUBs) sensitizes cancer cells to GSH depletion. Inhibition of GSH synthesis, in combination with DUB inhibition, led to an accumulation of polyubiquitinated proteins, induction of proteotoxic stress, and cell death. These results indicate that depletion of GSH renders cancer cells dependent on DUB activity to maintain protein homeostasis and cell viability and reveal a potentially exploitable vulnerability for cancer therapy.
在肿瘤的发生和发展过程中,细胞会受到氧化应激,这对癌细胞施加了选择性压力,使其适应耐受这些条件的机制。在这里,我们研究了癌症细胞对谷胱甘肽(GSH)的依赖性,GSH 是最丰富的细胞抗氧化剂。虽然癌细胞系对 GSH 合成抑制表现出广泛的敏感性,但大多数对 GSH 耗竭具有抗性。为了鉴定这种抗性所必需的细胞途径,我们进行了遗传和药理学筛选。这两种方法都表明,抑制去泛素化酶(DUBs)可使癌细胞对 GSH 耗竭敏感。GSH 合成的抑制与 DUB 抑制相结合,导致多泛素化蛋白的积累、蛋白毒性应激的诱导和细胞死亡。这些结果表明,GSH 的耗竭使癌细胞依赖 DUB 活性来维持蛋白质平衡和细胞活力,并揭示了癌症治疗中可能具有潜力的脆弱性。